Healthcare › Biotechnology
Vertex Pharmaceuticals
- Ticker
- VRTX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
Price data arrives in a later stage, so no price is shown yet.
Latest news
Company newsVRTX
Explain this story: $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Vertex Pharmaceuticals (NASDAQ: VRTX) has significantly outperformed the market over the last decade, with an average annual return of 19.81%. An initial investment of $100 in VRTX stock 10 years ago would now be worth $606.90. This demonstrates the substantial impact of compounded returns on investment growth over time.
OtherBenzingaSector and industry: HealthcareBiotechnologyTell me moreShow less
We have not explained this story yet. The original headline, summary and link are below.
Vertex Pharmaceuticals (NASDAQ: VRTX) has significantly outperformed the market over the last decade, with an average annual return of 19.81%. An initial investment of $100 in VRTX stock 10 years ago would now be worth $606.90. This demonstrates the substantial impact of compounded returns on investment growth over time.
Article tone: Neutral This describes the words the journalist used. It is not a prediction, and not advice.
Company newsVRTX
Explain this story: Autologous Hematopoietic Stem Cell Gene Therapy Market Global Report 2026: A $13.44 Billion Market by 2030 as Novartis, Vertex, CRISPR Therapeutics and Orchard Therapeutics Accelerate the Gene-Editing Race
The global autologous hematopoietic stem cell gene therapy market is projected to grow significantly, reaching $13.44 billion by 2030 from $5.23 billion in 2025, driven by advancements in gene-editing, increased investment in rare disease treatments, and personalized therapies. Key growth factors include commercialization of gene-editing therapies, regulatory approvals, adoption of personalized medicine, and infrastructure investments. North America was the largest regional market in 2025, with Asia-Pacific expected to be the fastest-growing region.
Other
Elsewhere
These links open other websites. We do not provide price data yet.